| Literature DB >> 26856728 |
F M Drost1, F Mols1,2, S E J Kaal3, W B C Stevens4, W T A van der Graaf3,5, J B Prins6, O Husson7.
Abstract
PURPOSE: The purpose of the study is to examine differences in perceived impact of cancer (IOC) between adolescents and young adults (AYAs; 18-35 years at cancer diagnosis), adults (36-64 years) and elderly (65-84 years) with a history of (non-)Hodgkin lymphoma. Furthermore, to investigate the association of socio-demographic, clinical and psychological characteristics with IOC; and the association between IOC and health-related quality of life (HRQoL) among AYAs only.Entities:
Keywords: Adolescent and young adult oncology; Health-related quality of life; Impact of cancer; Lymphoma
Mesh:
Year: 2016 PMID: 26856728 PMCID: PMC4920833 DOI: 10.1007/s11764-016-0518-7
Source DB: PubMed Journal: J Cancer Surviv ISSN: 1932-2259 Impact factor: 4.442
Sociodemographic and clinical characteristics of cancer survivors stratified by age
| AYA | Adults | Elderly |
| |
|---|---|---|---|---|
|
|
|
| ||
| Age (at time of diagnosis) (mean ± SD) | 28.0 (5.4) | 53.4 (8.0) | 71.4 (4.0) | <0.01 |
| Age (at time of survey) (mean ± SD) | 32.9 (6.0) | 58.5 (8.2) | 75.7 (4.0) | <0.01 |
| Tumour type | <0.01 | |||
| NHL | 33 (34 %) | 435 (86 %) | 245 (96 %) | |
| HL | 65 (66 %) | 71 (14 %) | 10 (4 %) | |
| Years since diagnosis (mean ± SD) | 5.0 (2.5) | 5.1 (2.6) | 4.3 (2.4) | <0.01 |
| Years since diagnosis | <0.01 | |||
| <2 years | 12 (12 %) | 68 (14 %) | 45 (18 %) | |
| 2–5 years | 39 (40 %) | 191 (38 %) | 128 (51 %) | |
| 5–10 years | 47 (48 %) | 233 (46 %) | 76 (30 %) | |
| > 10 years | 0 (0 %) | 11 (2 %) | 4 (2 %) | |
| Sex | 0.08 | |||
| Male | 49 (50 %) | 306 (60 %) | 161 (63 %) | |
| Female | 49 (50 %) | 200 (40 %) | 94 (37 %) | |
| Stage at diagnosis | <0.01 | |||
| I | 19 (19 %) | 120 (24 %) | 64 (25 %) | |
| II | 49 (50 %) | 92 (18 %) | 42 (17 %) | |
| III | 19 (19 %) | 71 (14 %) | 30 (12 %) | |
| IV | 10 (10 %) | 121 (24 %) | 59 (23 %) | |
| Unknown | 1 (1 %) | 102 (20 %) | 60 (24 %) | |
| Primary treatment | <0.01 | |||
| Radiotherapy alone | 5 (5 %) | 43 (9 %) | 23 (9 %) | |
| Chemotherapy alone | 38 (39 %) | 227 (46 %) | 125 (50 %) | |
| Chemotherapy + radiotherapy | 54 (55 %) | 98 (20 %) | 32 (13 %) | |
| Active surveillancea | 0 (0 %) | 121 (24 %) | 66 (26 %) | |
| Surgery | 1 (0.5 %) | 5 (0.7 %) | 0 (0 %) | |
| Transplantation | 0 (0 %) | 1 (0.2 %) | 0 (0 %) | |
| Other therapies | 1 (1 %) | 4 (1 %) | 6 (2 %) | |
| Comorbidity | <0.01 | |||
| None | 63 (64 %) | 187 (37 %) | 65 (26 %) | |
| 1 | 21 (21 %) | 154 (30 %) | 70 (28 %) | |
| 2 | 8 (8 %) | 83 (16 %) | 63 (25 %) | |
| 3 or more | 6 (6 %) | 82 (16 %) | 57 (22 %) | |
| Marital status | <0.01 | |||
| Married/cohabiting | 66 (68 %) | 426 (85 %) | 181 (74 %) | |
| Divorced/separated | 11 (11 %) | 29 (6 %) | 12 (5 %) | |
| Widowed | 1 (1 %) | 28 (6 %) | 42 (17 %) | |
| Never married/never cohabiting | 19 (20 %) | 19 (4 %) | 11 (5 %) | |
| Education level | <0.01 | |||
| Low | 1 (1 %) | 57 (11 %) | 64 (26 %) | |
| Medium | 54 (57 %) | 314 (63 %) | 138 (56 %) | |
| High | 40 (42 %) | 129 (26 %) | 43 (18 %) | |
| Current occupation | <0.01 | |||
| Employed | 64 (74 %) | 173 (37 %) | 2 (1 %) | |
| Not working/retired | 22 (26 %) | 296 (63 %) | 244 (99 %) |
AYA (18–35 years), Adults (36–64 years), Elderly (65–84 years): age at time of diagnosis
NHL non-Hodgkin lymphoma, HL Hodgkin lymphoma education levels included low no/primary school, medium lower general secondary education/vocational training, or high pre-university education/high vocational training/university
aPatients under active surveillance and receive no therapy
Mean scores of the Impact of Cancer (IOCv2) sub and total scales (±SD) according to age
| AYA | Adults | Elderly |
| |
|---|---|---|---|---|
|
|
|
| ||
| IOCv2 | Mean (SD) | Mean (SD) | Mean (SD) | |
| Altruism/empathy | 3.3 (0.7) | 3.2 (0.8) | 3.2 (0.9) | 0.64 |
| Health awareness | 3.5 (0.9) | 3.3 (0.8) | 3.0 (1.0) | <0.001ª |
| Meaning of cancer | 2.8 (0.8) | 2.7 (0.8) | 2.5 (0.9) | 0.001ª |
| Positive self-evaluation | 3.8 (0.7) | 3.4 (0.8) | 3.2 (0.9) | <0.001b |
| Appearance concerns | 1.8 (1.0) | 1.8 (0.8) | 1.8 (0.8) | 0.94 |
| Body change concerns | 2.6 (1.1) | 2.6 (1.0) | 2.6 (1.0) | 0.51 |
| Life interferences | 1.9 (0.5) | 2.0 (0.5) | 2.0 (0.5) | 0.09 |
| Worry | 2.6 (0.9) | 2.8 (0.9) | 2.6 (1.0) | 0.005 |
| Positive impact scale | 3.4 (0.6) | 3.1 (0.6) | 3.0 (0.7) | <0.001c |
| Negative impact scale | 2.2 (0.7) | 2.3 (0.7) | 2.2 (0.7) | 0.19 |
Bonferonni correction p = 0.01/10 = <0.001
IOCv2 Impact of Cancer Scale version 2: high scores representing greater impact
AYA (18–35 years), Adults (36–64 years), Elderly (65–84 years)
aBetween AYA and elderly and between adults and elderly
bBetween AYA and adults and between AYA and elderly
cBetween AYA and adults, between AYA and elderly and between adults and elderly
Multiple linear regression analyses of IOCv2 total and subscales of AYA lymphoma survivors (N = 98)
| Positive subscales | Negative subscales | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Positive impact | Altruism/empathy | Health awareness | Meaning of cancer | Positive self-evaluation | Negative impact | Appearance concerns | Body change concerns | Life interferences | Worry | |
| Bèta | Bèta | Bèta | Bèta | Bèta | Bèta | Bèta | Bèta | Bèta | Bèta | |
| Age (at time of survey) | 0.05 | 0.04 | 0.13 | −0.02 | −0.08 | 0.00 | 0.06 | −0.04 | −0.04 | 0.11 |
| Tumour type | ||||||||||
| NHL | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| HL | −0.03 | −0.06 | 0.10 | −0.10 | 0.06 | −0.13 | −0.17 | −0.03 | −0.11 | −0.02 |
| Years since diagnosis | ||||||||||
| ≤5 years | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| >5 years | 0.14 | 0.19 | 0.04 | 0.10 | 0.03 | −0.01 | −0.19 | 0.08 | −0.06 | 0.03 |
| Sex | ||||||||||
| Male | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| Female | 0.10 | −0.10 | 0.21 | −0.03 | 0.30* | 0.22* | 0.21* | 0.13 | 0.15 | 0.11 |
| Education | ||||||||||
| Low | −0.01 | 0.11 | 0.05 | −0.14 | −0.06 | 0.04 | −0.06 | 0.04 | −0.01 | 0.10 |
| Medium | −0.02 | −0.12 | −0.00 | −0.13 | 0.18 | 0.14 | 0.14 | 0.18 | 0.11 | 0.08 |
| High | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| Current occupation | ||||||||||
| Employed | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| Not working/retired | −0.06 | −0.01 | −0.11 | 0.17 | −0.25 | 0.09 | 0.16 | 0.10 | 0.12 | −0.04 |
| Marital status | ||||||||||
| No partner | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| Partner | 0.05 | 0.10 | 0.11 | −0.07 | −0.03 | 0.22* | 0.15 | 0.24* | 0.16 | 0.14 |
| Comorbidity | ||||||||||
| No | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| Yes | 0.07 | 0.03 | 0.02 | 0.01 | 0.08 | 0.15 | 0.24* | 0.17 | 0.08 | 0.06 |
| Psychological distress (HADS) | ||||||||||
| ≤15 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| >15 | 0.24 | 0.28* | 0.29* | 0.00 | 0.12 | 0.44** | 0.31** | 0.41** | 0.49** | 0.31** |
NHL non-Hodgkin lymphoma, HL Hodgkin lymphoma; Education levels included low = no/primary school, medium = lower general secondary education/vocational training, or high = pre-university education/high vocational training/university
HADS Hospital Anxiety Depression Scale
*p < 0.05; **p < 0.01
Multiple linear regression analyses of the association between IOCv2 total and subscales and HRQOL (EORTC QLQ-C30) subscales for the AYA lymphoma survivors
| Physical functioning | Role functioning | Emotional functioning | Cognitive functioning | Social functioning | Global health status | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bèta | Bèta | Bèta | Bèta | Bèta | Bèta | |||||||
| EORTC QLQ-C30 | Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted |
| Positive impact | −0.10 | −0.06 | 0.03 | 0.05 | −0.27** | −0.24* | −0.18 | −0.14 | −0.09 | −0.06 | −0.16 | −0.13 |
| Altruism/empathy | −0.01 | 0.04 | −0.30** | −0.21* | −0.06 | −0.25* | ||||||
| Health awareness | −0.17 | −0.13 | −0.31** | −0.30** | −0.25* | −0.21 | ||||||
| Meaning of cancer | −0.06 | 0.05 | −0.16 | 0.01 | 0.06 | −0.02 | ||||||
| Positive self-evaluation | 0.04 | 0.19 | −0.11 | 0.08 | 0.08 | 0.09 | ||||||
| Negative impact | −0.56** | −0.44** | −0.50** | −0.39** | −0.55** | −0.59** | −0.67** | −0.63** | −0.51** | −0.54** | −0.64** | −0.60** |
| Appearance concerns | −0.32** | −0.16 | −0.39** | −0.35** | −0.15 | −0.37** | ||||||
| Body change concerns | −0.49** | −0.38** | −0.55** | −0.58** | −0.50** | −0.59** | ||||||
| Life interferences | −0.42** | −0.39** | −0.57** | −0.64** | −0.61** | −0.59** | ||||||
| Worry | −0.29** | −0.29* | −0.42** | −0.37* | −0.31** | −0.39* | ||||||
Adjusted for age at time of survey, tumour type, years since diagnosis, sex, education, current occupation, marital status, comorbidity
EORTC QLQ C-30 European Organization for Research and Treatment of Cancer Quality of Life Core questionnaire, IOCv2 Impact of Cancer Scale version 2
*p < 0.05; **p < 0.01